Table 1.

Association between lncNT5E expression and clinicopathological parameters of PC patients

Characteristics	No of cases	lncNT5E level		χ 2	P‐value
		High	Low
Total cases	45	23	22
Gender a
Male	33	19	14	2.070	.150
Female	12	4	8
Age (years) a
>60	30	15	15	0.044	.833
≦60	15	8	7
Tumour location a
Head	28	16	12	1.079	.299
Body and tail	17	7	10
Differentiation b
High	2	0	2	2.961	.228
Moderate	13	7	6
Low	30	16	14
Perineural invasion a
Yes	33	18	15	0.584	.445
No	12	5	7
TNM stage (AJCC) b , c
I	18	5	13	6.719	.035*
II	24	16	8
III	3	2	1
T stage b
T1	11	4	7	2.709	.258
T2	26	16	10
T3	8	3	5
Lymph node metastasis b
N0	21	6	15	9.195	.010**
N1	20	15	5
N2	4	2	2

Abbreviations: No of cases, number of cases; T stage, tumour stage; TNM, tumour‐node‐metastasis.

^aPearson chi‐squared test.

^bFisher's exact test.

^cAmerican Joint Committee on Cancer (AJCC), patients were staged in accordance with the 8th Edition of the AJCC Cancer TNM Classification.

^* P < .05.

^** P < .01.